| Dr Christopher Lahr, | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 925-6805 | |
| (601) 926-4978 |
| Full Name | Dr Christopher Lahr |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 49 Years |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548294580 | NPI | - | NPPES |
| 157111 | Medicaid | AL | |
| 2167413 | Medicaid | LA | |
| 06507067 | Medicaid | MS | |
| P00704066 | Other | MS | RAILROAD MEDICARE |
| 183142 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 19900 (Mississippi) | Primary |
| 208C00000X | Colon & Rectal Surgery | 14371 (South Carolina) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Skilled Facility Health Care Solutions Inc | 9032299144 | 55 |
News Archive
The amount Americans spend on healthcare out of pocket reached $416 billion in 2014 and with growth of 8% will reach $608 billion by 2015. Americans spend on three categories out of pocket: directly on expenditures, co-pays as part of office visits and hospital visits and drug purchases, and on premiums.
Trying to explain riding a bike is difficult because it is an implicit memory. The body knows what to do, but thinking about the process can often interfere. So why is it that under certain circumstances paying full attention and trying hard can actually impede performance? A new UC Santa Barbara study, published today in the Journal of Neuroscience, reveals part of the answer.
During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.
With some of the lowest death and incidence rates for cancers, British Columbia is leading Canada in the battle against cancer.
KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced treatment of the first patient in a Phase 1 clinical trial of KB004, its first-in-class Humaneered™ monoclonal antibody, in EphA3-expressing hematologic malignancies.
› Verified 5 days ago
| Entity Name | Skilled Facility Health Care Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104018423 PECOS PAC ID: 9032299144 Enrollment ID: O20170712000468 |
News Archive
The amount Americans spend on healthcare out of pocket reached $416 billion in 2014 and with growth of 8% will reach $608 billion by 2015. Americans spend on three categories out of pocket: directly on expenditures, co-pays as part of office visits and hospital visits and drug purchases, and on premiums.
Trying to explain riding a bike is difficult because it is an implicit memory. The body knows what to do, but thinking about the process can often interfere. So why is it that under certain circumstances paying full attention and trying hard can actually impede performance? A new UC Santa Barbara study, published today in the Journal of Neuroscience, reveals part of the answer.
During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.
With some of the lowest death and incidence rates for cancers, British Columbia is leading Canada in the battle against cancer.
KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced treatment of the first patient in a Phase 1 clinical trial of KB004, its first-in-class Humaneered™ monoclonal antibody, in EphA3-expressing hematologic malignancies.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Lahr, 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 925-6805 | Dr Christopher Lahr, 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 925-6805 |
News Archive
The amount Americans spend on healthcare out of pocket reached $416 billion in 2014 and with growth of 8% will reach $608 billion by 2015. Americans spend on three categories out of pocket: directly on expenditures, co-pays as part of office visits and hospital visits and drug purchases, and on premiums.
Trying to explain riding a bike is difficult because it is an implicit memory. The body knows what to do, but thinking about the process can often interfere. So why is it that under certain circumstances paying full attention and trying hard can actually impede performance? A new UC Santa Barbara study, published today in the Journal of Neuroscience, reveals part of the answer.
During each cell division, more than 3.3 billion base pairs of genomic DNA have to be duplicated and segregated accurately to daughter cells. But what happens when the DNA template is damaged in such a way that the replication machinery gets stuck? To answer this question, scientists in the team of Matthias Mann at the Max Planck Institute of Biochemistry in Martinsried near Munich, with colleagues in Copenhagen and at Harvard, have analyzed how the protein composition of the DNA replication machinery changes upon encountering damaged DNA.
With some of the lowest death and incidence rates for cancers, British Columbia is leading Canada in the battle against cancer.
KaloBios Pharmaceuticals, Inc., a privately held biopharmaceutical company, today announced treatment of the first patient in a Phase 1 clinical trial of KB004, its first-in-class Humaneered™ monoclonal antibody, in EphA3-expressing hematologic malignancies.
› Verified 5 days ago
Dr. Wayne Shannon Orr Iii, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5452 Fax: 601-815-3322 | |
Jacob M Folse, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-5153 Fax: 601-984-6962 | |
Robert Eugene Schmieg Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 Fax: 601-926-4978 | |
Dr. Hal Gregory Fiser, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1190 N State St, Suite 502, Jackson, MS 39202 Phone: 601-944-1781 Fax: 601-353-0439 | |
Pierre Edouard De Delva, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2500 N State St, University Of Mississippi Medical Center, Jackson, MS 39216 Phone: 601-984-5170 | |
Dr. John Magruder Sullivan Iii, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-984-1000 | |
Colton Lott, Surgery Medicare: Not Enrolled in Medicare Practice Location: 2500 N State St, Jackson, MS 39216 Phone: 601-815-1292 Fax: 601-984-5110 |